| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1084269A4 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 02/09/2005 | EP1071417B1 Use of cannabidiol as anti-inflammatory agent |
| 02/09/2005 | CN1578777A Manufacture of alpha- tocopherol |
| 02/09/2005 | CN1578776A Heterocyclic retinoid compounds |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578624A Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
| 02/09/2005 | CN1576278A Colorant compounds |
| 02/09/2005 | CN1188406C Cattail pollen extract and preparation process and use thereof |
| 02/03/2005 | WO2005010160A2 Liquid crystals with reduced toxicity and applications thereof |
| 02/03/2005 | WO2005009391A2 Antibiotic compound |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | WO2004069774A3 Synthesis of 13c-labelled estrogen analogues |
| 02/03/2005 | DE10329874A1 Tajixanthonhydrat und Tajixanthonhydrat-Derivate, Verfahren zu ihrer Isolierung und Herstellung, biologische Aktivitäten und deren Verwendung Tajixanthonhydrat and Tajixanthonhydrat derivatives, processes for their isolation and preparation, biological activities and their use |
| 02/03/2005 | CA2532802A1 Antibiotic compound isolated from streptomyces sp |
| 02/02/2005 | EP1502915A1 Compounds with a sulfamate group |
| 02/02/2005 | EP1501525A1 Method for producing preparations rich in tocotrienol |
| 02/02/2005 | EP1501497A2 Catechin multimers as therapeutic drug delivery agents |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1572762A Process for producing chroman-carboxylic acid |
| 02/02/2005 | CN1572755A Cherry leaf extract and its preparation method |
| 02/01/2005 | US6849746 Synthetic methods for polyphenols |
| 02/01/2005 | US6849745 Fluorescent dye for use in the detection of preferential compounds |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 02/01/2005 | US6849646 Chromenone and chromanone derivatives as integrin inhibitors |
| 01/27/2005 | WO2005007678A2 Methods for the preparation of rhodamine |
| 01/27/2005 | WO2005007650A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |
| 01/27/2005 | WO2005007640A1 Preventive or therapeutic composition for viral infectious disease |
| 01/27/2005 | WO2004085418A3 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 01/27/2005 | WO2004041804B1 Technical process for isolating homoeriodictyol |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease |
| 01/27/2005 | US20050020512 In presence of acidic clay; coupling in presenc eof silver tetrafluoroborate ; anticancer agents |
| 01/27/2005 | US20050019389 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/27/2005 | CA2496130A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1032568B1 Process for the preparation of isoflavones |
| 01/26/2005 | CN1569850A Fixed bed hydrolysis method for glycoside type soy bean isoflavone materials |
| 01/26/2005 | CN1569812A Aromatic tetramine monomer and aromatic tetramine chydrochloride and their preparation process |
| 01/26/2005 | CN1568669A Method for producing active ingredient of snow lotus flavone by cultivating hairly root of S.involucrata |
| 01/26/2005 | CN1186337C Method for preparing DL-alpha-tocopherol with high yield |
| 01/26/2005 | CN1186336C Prepn and application in preparing medicine of fraxinus general coumarin |
| 01/26/2005 | CN1186309C Process for producing 3-isochromanone |
| 01/20/2005 | WO2005005408A1 Amine compound and uses thereof |
| 01/20/2005 | WO2005005407A1 Manufacture of tocopherols using a bismuth catalyst |
| 01/20/2005 | WO2005005401A1 Sulfonic ester compound and fluorescent probe employing the same |
| 01/20/2005 | WO2005005400A1 Sulfonate compound and fluorescent probe using the same |
| 01/20/2005 | WO2005005356A2 Enantioselective synthesis of enantiomerically enriched compounds |
| 01/20/2005 | WO2004099145A3 Phenyl substituted cyclic derivatives |
| 01/20/2005 | WO2004096857A3 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 01/20/2005 | WO2004089926A8 Genipin derivatives and uses thereof |
| 01/20/2005 | WO2003099762A8 Agents and methods for the treatment of disorders associated with oxidative stress |
| 01/20/2005 | US20050014958 Oxidizing hydroxyl-protected benzylepitcatechin, adding nucleophilic aryl-organometallic reagent, and deoxygenating forming compounds such as 3,5,7,3',4'-penta-o-benzyl-4-hydroxyepicatechin; procyanidins |
| 01/20/2005 | US20050014819 Prenylflavonoids, chalcone derivatives, flavonols and/or glycosides; plant extracts; foods, beverages; insulin resistance |
| 01/20/2005 | US20050014818 Process for producing optically active chroman derivative and intermediate |
| 01/20/2005 | US20050014750 Isochroman compounds for treatment of cns disorders |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050011411 Anthraquinone, xanthene dyes: coloring ink |
| 01/20/2005 | DE10343746B3 Production of vitamin E succinate compactate, useful for making pressed molding, especially tablets, uses relatively low temperature for compacting in press agglomerator, milling and classification |
| 01/19/2005 | EP1497277A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 01/19/2005 | CN1566109A Aldose reductase inhibitor, preparation method and use thereof |
| 01/19/2005 | CN1566108A Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 01/19/2005 | CN1566107A Extraction method of baicalin element and application in antiinflammation and ease pain thereof |
| 01/19/2005 | CN1566072A Method for preparing 2-halomethyl phenylacetiate |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/13/2005 | WO2005003085A2 Tajixanthone hydrate and tajixanthone hydrate derivatives, biological activities thereof, and use thereof |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050010050 Antiinflammatory agents; antiarthritic agents; anticancer agents; analgesics |
| 01/13/2005 | US20050010040 Generating proanthocyanidins from crude plant extracts; for use in treating inflammation and gastrointestinal disorders; for use as meat additives to inhibit food-borne pathogens |
| 01/13/2005 | US20050009903 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy- Delta 8-tetrahydrocannabinols and 1-alkyl-3(1-naphthoyl)indoles, useful for the treatment of pain (especially pain resulting from inflammation) and cancer (especially glioma tumors). |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | DE10328049A1 Neue antimikrobielle Chroman-4-one New antimicrobial chroman-4-one |
| 01/12/2005 | EP1496045A2 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process |
| 01/12/2005 | EP1495014A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494691A2 Treatment of diseases involving defective gap junctional communication |
| 01/12/2005 | EP1355906B1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 01/12/2005 | EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | CN1564818A Process for stereoselective synthesis of 2-hydroxymethyl chromans |
| 01/12/2005 | CN1563028A Flavonoid extract product containing pedaliin and application |
| 01/12/2005 | CN1562996A Extract products of exopleura of sorghum, extracting method and application |
| 01/12/2005 | CN1562995A Left ofloxacin and Pidotimod compound preparation tech and its appts. |
| 01/12/2005 | CN1562994A Producing technique for extracting extract products of amentoflavone |
| 01/12/2005 | CN1562993A New technique for synthesizing 7, 8 dihydroxyl coumarin |
| 01/12/2005 | CN1562992A Technique for extracting general coumarin and monomer components from cnidium fruit and medicinal preparation |
| 01/12/2005 | CN1562991A New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg |
| 01/11/2005 | US6841687 Solvent extracting from wood powder using chloroform and methanol; concentration under vacuum; adsorption of methanol on silica gel |
| 01/11/2005 | US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions |
| 01/11/2005 | US6841183 Process for producing aspartame derivatives, process for purifying aspartame derivatives, production intermediates, and process for producing production intermediates |
| 01/06/2005 | WO2005000831A1 ESTERS OF FLAVONOIDS WITH ω-SUBSTITUTED C6-C22 FATTY ACIDS |
| 01/06/2005 | WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | WO2004096791A3 Process for the manufacture of tocyl and tocopheryl acylates |
| 01/06/2005 | WO2004052873A3 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 01/06/2005 | US20050004377 Reacting chroman-2-yl ether with base under anhydrous conditions; adding proton doner; forming 2-hydroxychroman; condensating with nucleophilic compound; anticoagulants |